Enduring Activity: Pharmacology Series: Updates in Guidelines “Adult Heart Failure and SGLT2”

Evaluation and Credit: https://www.surveymonkey.com/r/2024Ph...

Target Audience
This activity is designed for primary care physicians and advanced practice providers.

Statement of Need
Practice rapidly evolves with the development of new pharmacological interventions. Providers are not always aware of the latest pharmacology guidelines and updates in the treatment of chronic medical conditions.

Objectives
At the conclusion of this offering, the participant will be able to:
1. Review pharmacology of SGLT2 inhibitors.
2. Interpret guideline recommendations for SGLT2 inhibitor use.
3. Apply evidencebased recommendations to patient case.

Faculty
Justin McCann, PharmD, MBA, BCACP
Transitions of Care Clinical Pharmacist Specialist
Norton Healthcare

Faculty Disclosure
Faculty for this activity have no relevant financial relationships with ineligible companies.

Planner and Moderator Disclosure
Amanda Thurman, PharmD, is a planner for the activity and has the following relationship to disclose; speakerNovo Nordisk. No other planners or the moderator of this event have relevant relationships with ineligible companies to disclose. All relevant financial relationships have been mitigated.

Commercial Support
This activity has not received commercial support.

Accreditation
Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

Designation
Norton Healthcare designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits
Norton Healthcare Institute for Education and Development is approved with distinction as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing professional development activity has been approved for 1.0 contact hours. Norton Healthcare is also a Kentucky Board of Nursing (KBN) Approved Provider: Activity Number 400021224197. The activity has also been approved by Norton Healthcare for 1.0 contact hours, which expires 12/31/2024. KBN approval of a continuing education provider does not constitute endorsement of program content. This activity/session meets 1.0 contact hour of approved pharmacology CE required by the Kentucky Board of Nursing (KBN) for annual APRN license renewal – 201 KAR 20:215.
In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance. For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANEA, AFNBC at (502) 4465889 or [email protected].

Date of Original Release | June 27, 2024

Course Termination Date | June 2026

Contact Information | Center for Continuing Medical Education; (502) 4465955 or [email protected]

Resources

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
https://pubmed.ncbi.nlm.nih.gov/35379...

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/36027...

SodiumGlucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
https://pubmed.ncbi.nlm.nih.gov/30665...

Join our online community and stay connected with Norton Healthcare for the latest news, events, and resources to support your wellbeing. ⬇
Facebook:   / nortonhealthcare  
X (Twitter):   / norton_health  
Instagram:   / nortonhealth  
LinkedIn:   / nortonhealthcare  
TikTok:   / nortonhealthcare